Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03492762
EARLY_PHASE1

PET Imaging CCR2 in Lung Inflammation

Sponsor: Washington University School of Medicine

View on ClinicalTrials.gov

Summary

The primary objective of this study is to assess the lung distribution of the Positron Emission Tomography (PET) imaging radiotracer Cu-DOTA-ECL1i, which binds to the specific population inflammatory cells, in patients with fibrotic lung diseases. This objective includes sub-studies to assess radiotracer distribution in the lung, the reproducibility of PET scans and the relationship of the scan to distribution of inflammatory cells in human lung tissue. The overall goal is to assess the potential of the radiotracer to track inflammatory cells in lung diseases.

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

110

Start Date

2018-02-27

Completion Date

2026-12-31

Last Updated

2025-05-30

Healthy Volunteers

Yes

Interventions

DRUG

Cu-DOTA-ECL1i

Radiolabeled probe called Cu-DOTA-ECL1i that recognizes CCR2 and propose to image CCR2 in the lung to ultimately guide diagnosis and therapy.

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States